Skip to content

Marex Group stock

MRXNASDAQ

Marex Group Limited, Financial ServicesISIN BMG5T40M1045

$71.67▼ $2.26 (−3.1%)Closing price of 12 Nov 2026

79Score 79 out of 100, Strong

Turn on early warning

Price and trend

88 / 100

Price history

+105% in one year

The chart shows daily closes over 3 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 23% above it.

Trend change

Since January 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 53).

Distance to the high

The price is 8.4% below its 52-week high. Largest decline in 3 years: 42% (May 2025 to October 2025).

Chart figures for advanced users
SMA 50$71.16
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$58.41
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)53
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$31.82
The lowest closing price of the last twelve months.
Resistance$78.27
The highest closing price of the last twelve months.
Market cap
$5.32B
Div. yield
0.84%
12 months
13.3
10.7
on earnings for the next twelve months ($6.90 per share)
Fair value
$58.02

Snapshot

Computed from the data by fixed rules, no AI

  • Marex Group Limited belongs to the Financial (Capital Markets) industry (United Kingdom) and, with a market value of $5.16B, is number 46 of 81 companies in its industry on MEQIRI.
  • In fiscal 2025 it earned $308.2M (up 41.4% year on year).
  • MEQIRI Score 79 out of 100 (Strong): rank 110 of 976 in Financial Services, median 68.
Show more
  • The P/E is 12.9 (Financial (Capital Markets) median 13.7, own median of recent years 10.4).
  • Our model puts fair value at $58.02, with the price 27% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings per share growingUp 41.8% a year since 2020.Growth 100
  • High return on equityReturn on equity 26.7% over the last 12 months.Profitability 83
  • Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 100

Weaknesses

  • DilutionShare count up 18% since 2020.Capital allocation 56
  • High leverageTotal assets 22.5 times equity.Stability 30
  • Volatile share priceVolatility 47% a year over the last 12 months.Stability 30
79/ 100
MEQIRI Score
Strong

Its standout strengths are fundamentals and growth, while stability holds the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 77 to 79.

The fundamentals are strong overall.

Profit consistency100% of years
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)26.7%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price up very strongly over the past year
  • high growth grade (crashed more often in the backtest)

What lowers it

  • solid fundamentals
  • price near its 52-week high

Valuation

Valuation signal

Modestly overvalued
Price
$73.93
Fair value
$58.02
Gap to fair value
+27%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $41.44 and expensive above $96.70 (uncertainty high, based on the price swings of the past year).

The two parts of the fair value come to $39.86 (excess return model) and $76.18 (industry comparison), and the gap between them shows how uncertain the estimate is.

Calculated with a cost of equity of 12.1%. At 13.1% the fair value would be $55.87, at 11.1% it would be $60.76.

Valuation metrics

2.9
26.7%
last 12 months, profit over average equity
Fair value (model)
$58.02
Earnings part $76.18 (earnings per share $5.55 × 13.7)

Half from the excess return model, half from earnings times the industry P/E (13.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

13 years

In fiscal 2025, revenue rose 21.8% on the prior year. Revenue has grown strongly since 2013, at around 19% per year.

Margins

13 years
  • Operating margin
  • Net margin

In fiscal 2025: operating 40%, net 11%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.

Debt & balance sheet

Fiscal 2025
8.1
Equity
$1.26B
3.16
Cash & equivalents
$13.46B

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
2 Mar 2027in 110 days
Last reported
5 Nov 2026EPS reported $1.67 (expected $1.54)above expectations

Analyst estimates

Earnings estimates have barely changed since 15 Oct 2026.

Fiscal 20265 analysts
Earnings per share
$6.18−0.4%
Revenue
$2.77B+0.1%
Fiscal 20276 analysts
Earnings per share
$7.01+0.5%
Revenue
$3.06B+0.1%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: +20.7%

No guidance: after the exceptional conditions of the first quarter, more typical quarters with the center of profits further to the right are expected.

Supporting passage from the call, verbatim
“I expect that as we move past the exceptional conditions of Q1, the distribution will become more typically bell-shaped with the center of the distribution further to the right, reflecting our growth.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 12 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

No open-market purchases in the last 6 months. 5 insiders sold, $14.24M in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Van Den Born SimonSale

    5 Nov 2026, President

    Shares
    22,456
    Price
    $66.29
    Value
    $1.49M
  • Van Den Born SimonSale

    12 Oct 2026, President

    Shares
    15,272
    Price
    $72.04
    Value
    $1.1M
  • Tonucci PaoloSale

    12 Oct 2026, See Remarks

    Shares
    16,666
    Price
    $72.03
    Value
    $1.2M
Show 9 more
  • Tonucci PaoloSale

    14 Sept 2026, See Remarks

    Shares
    16,666
    Price
    $70.87
    Value
    $1.18M
  • Van Den Born SimonSale

    14 Sept 2026, President

    Shares
    15,271
    Price
    $70.87
    Value
    $1.08M
  • Irvin RobSale

    14 Aug 2026, Chief Financial Officer

    Shares
    3,700
    Price
    $70.96
    Value
    $262,545
  • Tonucci PaoloSale

    10 Aug 2026, See Remarks

    Shares
    16,668
    Price
    $60.92
    Value
    $1.02M
  • Lowitt Ian TSale

    13 Jul 2026, Chief Executive Officer

    Shares
    37,142
    Price
    $64.39
    Value
    $2.39M
  • Tonucci PaoloSale

    13 Jul 2026, See Remarks

    Shares
    16,666
    Price
    $64.42
    Value
    $1.07M
  • Tonucci PaoloSale

    15 Jun 2026, See Remarks

    Shares
    16,666
    Price
    $62.45
    Value
    $1.04M
  • Lowitt Ian TSale

    12 Jun 2026, Chief Executive Officer

    Shares
    37,143
    Price
    $62.37
    Value
    $2.32M
  • Texier ThomasSale

    1 Jun 2026, Group Head of Clearing

    Shares
    1,572
    Price
    $53.35
    Value
    $83,865

Partial trades from one filing are shown in one row, with the average price.

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Marex Group

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 110 of 976
110/ 976
This company
79
Sector median
68

Categories against the sector median

ProfitabilityMedian of 976 companies83 (median 57)26 above the median
GrowthMedian of 976 companies100 (median 67)33 above the median
FundamentalsMedian of 976 companies100 (median 80)20 above the median
ValuationMedian of 929 companies with a value58 (median 73)15 below the median
StabilityMedian of 976 companies30 (median 78)48 below the median
Capital allocationMedian of 976 companies56 (median 56)0 at the median
Technical analysisMedian of 976 companies88 (median 70)18 above the median
MomentumMedian of 976 companies88 (median 70)18 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Financial (Capital Markets)

The next larger and next smaller companies by market value

All 81 Financial (Capital Markets) stocks

ETFs that hold Marex Group

Held by 4 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 1 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 27 Mar 2026)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy